Artikel

Zahl privater Zusatzkrankenversicherungen hat sich verdoppelt

Given the growing variety of expensive treatments and drugs, economic sustainability is a particular challenge for healthcare systems with universal insurance coverage. Patient co-payment regimes for prescription drugs are a proven means of cost containment worldwide. However, there is little empirical evidence on the optimal design of co-payment regulation. A study of the effects of a regulatory reform on pharmaceutical demand and expenditures in Denmark shows how market-oriented regulation can lead to substantial savings for consumers and healthcare systems.

Language
Deutsch

Bibliographic citation
Journal: DIW Wochenbericht ; ISSN: 1860-8787 ; Volume: 81 ; Year: 2014 ; Issue: 14 ; Pages: 302-307 ; Berlin: Deutsches Institut für Wirtschaftsforschung (DIW)

Classification
Wirtschaft
Health: Government Policy; Regulation; Public Health
Single Equation Models; Single Variables: Panel Data Models; Spatio-temporal Models
Subject
pharmaceutical markets
regulation
co-payments
reference pricing

Event
Geistige Schöpfung
(who)
Grabka, Markus M.
Event
Veröffentlichung
(who)
Deutsches Institut für Wirtschaftsforschung (DIW)
(where)
Berlin
(when)
2014

Handle
Last update
10.03.2025, 11:41 AM CET

Data provider

This object is provided by:
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. If you have any questions about the object, please contact the data provider.

Object type

  • Artikel

Associated

  • Grabka, Markus M.
  • Deutsches Institut für Wirtschaftsforschung (DIW)

Time of origin

  • 2014

Other Objects (12)